Catalogo dei prodotti della ricerca

FOA, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.490
EU - Europa 13.075
AS - Asia 7.333
SA - Sud America 535
AF - Africa 160
OC - Oceania 35
Continente sconosciuto - Info sul continente non disponibili 10
Totale 55.638
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.079
IT - Italia 4.902
SG - Singapore 3.126
SE - Svezia 2.418
CN - Cina 1.875
IN - India 1.840
UA - Ucraina 1.053
FI - Finlandia 979
RU - Federazione Russa 863
DE - Germania 816
GB - Regno Unito 489
RO - Romania 375
CA - Canada 352
BR - Brasile 326
IE - Irlanda 245
BG - Bulgaria 209
AR - Argentina 157
NL - Olanda 132
FR - Francia 129
BE - Belgio 105
TG - Togo 97
ID - Indonesia 78
AT - Austria 76
TR - Turchia 59
HK - Hong Kong 58
CH - Svizzera 53
GR - Grecia 51
JP - Giappone 41
MX - Messico 41
KR - Corea 36
TH - Thailandia 32
AU - Australia 30
ES - Italia 30
LT - Lituania 29
ZA - Sudafrica 24
CL - Cile 18
IL - Israele 18
MY - Malesia 17
PL - Polonia 16
EC - Ecuador 15
PH - Filippine 15
IR - Iran 14
PK - Pakistan 14
SA - Arabia Saudita 14
AE - Emirati Arabi Uniti 13
IQ - Iraq 12
TW - Taiwan 12
AL - Albania 11
BD - Bangladesh 10
PT - Portogallo 10
DK - Danimarca 9
EU - Europa 9
HR - Croazia 9
KE - Kenya 9
KZ - Kazakistan 9
MA - Marocco 9
SC - Seychelles 9
NO - Norvegia 8
RS - Serbia 8
CO - Colombia 7
CZ - Repubblica Ceca 7
HU - Ungheria 7
LV - Lettonia 7
MK - Macedonia 7
UZ - Uzbekistan 7
PE - Perù 6
AZ - Azerbaigian 5
EE - Estonia 5
LK - Sri Lanka 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
DO - Repubblica Dominicana 4
EG - Egitto 4
GT - Guatemala 4
JM - Giamaica 4
LU - Lussemburgo 4
PA - Panama 4
AM - Armenia 3
BH - Bahrain 3
ME - Montenegro 3
VN - Vietnam 3
CR - Costa Rica 2
LI - Liechtenstein 2
NG - Nigeria 2
PY - Paraguay 2
RE - Reunion 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
VE - Venezuela 2
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
DZ - Algeria 1
IM - Isola di Man 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
Totale 55.630
Salva come PNG Salva come JPEG
Città #
Fairfield 5.707
Woodbridge 2.641
Chandler 2.364
Ashburn 2.355
Seattle 2.102
Houston 2.008
Singapore 1.977
Wilmington 1.938
Cambridge 1.735
Rome 1.382
Ann Arbor 1.368
Beijing 1.204
Princeton 1.148
Plano 862
San Paolo di Civitate 812
Santa Clara 633
Boston 581
Lawrence 566
Millbury 420
Dearborn 419
San Diego 413
Jacksonville 380
Des Moines 319
Andover 277
Dublin 244
Moscow 214
Toronto 202
Sofia 201
Helsinki 199
Bremen 194
Norwalk 185
Milan 174
New York 165
Southend 159
Boardman 154
Federal 133
Stockholm 129
Falkenstein 107
Ottawa 102
Brussels 100
Lomé 97
Falls Church 95
San Mateo 95
Yubileyny 89
Bühl 76
Nuremberg 74
Bologna 72
Council Bluffs 72
Jakarta 72
Florence 71
Mannheim 68
Hefei 62
Nanjing 54
Kunming 50
Istanbul 49
London 48
Los Angeles 47
Vienna 43
Naples 38
Frankfurt am Main 37
Guangzhou 34
Buffalo 33
Redmond 32
Turin 32
Bangkok 31
Phoenix 31
Auburn Hills 29
Indiana 29
Hong Kong 26
São Paulo 26
Redwood City 23
Bari 22
Genoa 22
Jinan 22
Pune 22
Mumbai 21
Amsterdam 20
Chicago 20
Paris 20
Fremont 19
Fasano 17
Mexico City 17
Trento 17
Laurel 16
Muizenberg 16
Munich 16
Torino 16
Genova 15
Lappeenranta 15
Nanchang 15
Napoli 15
Belo Horizonte 14
Catania 14
Grafing 14
Simi Valley 14
Springfield 14
Tel Aviv 14
Tokyo 14
Westminster 14
Chieuti 13
Totale 38.396
Salva come PNG Salva come JPEG
Nome #
Terapia di salvataggio con il protocollo IEV seguito da chemioterapia ablativa e trapianto autologo in pazienti affetti da Hodgkin refrattari o in recidiva: risultati in 23 pazienti con età <18 anni alla diagnosi. 1.580
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 241
Biallelic BIRC3 inactivation in chronic lymphocytic leukaemia patients with 11q deletion identifies a subgroup with very aggressive disease. 153
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study. 139
Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? 126
Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913 126
Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC). 123
Clinical relevance of silent red blood cell autoantibodies. 122
Childhood polycythemia vera and essential thrombocythemia: Does their pathogenesis overlap with that of adult patients? 120
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma 120
EFFICACY, SAFETY AND COST ANALYSIS OF SUBCUTANEOUS VS INTRAVENOUS RITUXIMAB IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA TREATED WITH RCHOP 117
The revised WHO diagnostic criteria for Ph-negative myeloproliferative diseases are not appropriate for the diagnostic screening of childhood polycythemia vera and essential thrombocythemia 116
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: The growing saga of the IGHV3 subgroup gene usage 116
Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma 115
Markers of myeloproliferative diseases in childhood polycythemia vera and essential thrombocythemia. 114
MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma. 113
The deregulated expression of miR-125b in acute myeloid leukemia is dependent on the transcription factor C/EBPalpha 113
A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients. Final results of the GIMEMA LAL1509 protocol 112
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase 112
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 110
Splenic marginal zone lymphoma : Prognostic factors ,role of watch and wait policy ,and othert herapeutic approaches in the rituximab era 110
Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP). 108
Daratumumab, bortezomib, and dexamethasone for multiple myeloma 108
Repeated infusions of escalating doses of expanded and activated autologous natural killer cells in minimal residual disease-positive Ph+ acute lymphoblastic leukemia patients. A GIMEMA phase 1 trial 108
Epidemiology, features and outcome of pain in patients with advanced hematological malignancies followed in a home care program: An Italian survey 107
Growth-inhibitory and antiangiogenic activity of the MEK inhibitor PD0325901 in malignant melanoma with or without BRAF mutations. 106
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 106
Comparative analysis between RQ-PCR and digital-droplet-PCR of immunoglobulin/T-cell receptor gene rearrangements to monitor minimal residual disease in acute lymphoblastic leukaemia 106
GIMEMA-AIEOP AIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children. 106
Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma 103
A novel heterozygous HIF2AM535I mutation reinforces the role of oxygen sensing pathway disturbances in the pathogenesis of familial erythrocytosis. 103
Epigenetic alteration of SOCS family members is a possible pathogenetic mechanism in JAK2 wild type myeloproliferative diseases 102
Efficacy and safety of long term tenofovir in high risk patients with hematological malignancies (HM) to prevent Hepatitis B Virus (HBV) reactivation after immunosuppressive therapies in real life 102
DROPLET DIGITAL PCR DETECTION OF THE T315I BCR::ABL1 KD MUTATION IN ADULT PH-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA 101
Somatic alterations of the androgen receptor CAG repeat in human colon cancer delineate a novel mutation pathway independent of microsatellite instability. 101
A case of late isolated ovarian relapse of acute lymphoblastic leukemia after an allogeneic stem cell transplant. 101
Effect of low or high doses of low-molecular-weight heparin on thrombin generation and other haemostasis parameters in critically ill patients with COVID-19 101
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia 101
The therapeutic response and clinical outcome of adults with ALL1(MLL)/AF4 fusion positive acute lymphoblastic leukemia according to the GIMEMA experience. 100
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: Evidence of NPM1 mutation stability 99
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 99
Secondary acute myeloid leukaemia: results of conventional treatments. Experience of GIMEMA trials 99
A novel point mutation within the juxtamembrane domain of the flt3 gene in acute myeloid leukemia 98
Interleukin (IL)-3/granulocyte macrophage-colony stimulating factor/IL-5 receptor alpha and beta chains are preferentially expressed in acute myeloid leukaemias with mutated FMS-related tyrosine kinase 3 receptor 97
The changing scene of adult acute lymphoblastic leukemia 97
Atypical presentation of anaplastic large T-cell lymphoma mimicking an articular relapse of rheumatoid arthritis in a patient treated with etanercept. A case report and literature review 97
Platelet activation and multidrug resistance protein-4 expression in children and adolescents with different subtypes of primary thrombocythemia 97
Interleukin-12 is synthesized by mesangial cells and stimulates platelet-activating factor synthesis, cytoskeletal reorganization, and cell shape change. 96
Efficacy of the BEACOPP regimen in refractory and relapsed Hodgkin lymphoma. 96
Accessory cells, cytokine loops and cell-to-cell interactions in chronic lymphocytic leukemia. 96
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain react 96
Prognostic and therapeutic role of targetable lesions in B-lineage acute lymphoblastic leukemia without recurrent fusion genes 95
Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP). 94
Diversity and functional consequences of germline and somatic PTPN11 mutations in human disease 94
Combined interphase fluorescence in situ hybridization elucidates the genetic heterogeneity of T-cell acute lymphoblastic leukemia in adults 94
Atypical chronic myeloid leukemia in a patient with aplastic anemia 94
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis. 93
A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis 93
Aplastic Anemia and Good Syndrome in a Heavily Treated Stage IV Thymoma Patient: A Case Report and Review of the Literature 93
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 92
Comparative analysis between RQ-PCR and digital droplet PCR of BCL2/IGH gene rearrangement in the peripheral blood and bone marrow of early stage follicular lymphoma 92
Functional analysis and gene expression profile of umbilical cord blood regulatory T cells 92
Clinically Driven Diagnostic Antifungal Approach in Neutropenic Patients: A Prospective Feasibility Study 91
Primary mediastinal lymphoma: diagnosis and treatment options. 91
Practical management of ibrutinib in the real life: Focus on atrial fibrillation and bleeding 91
Adolescent and young adult acute lymphoblastic leukemia. Final results of the phase II pediatric-like GIMEMA LAL-1308 trial 91
PLZF-mediated control on c-kit expression in CD34(+) cells and early erythropoiesis. 90
A mammalian microRNA expression atlas based on small RNA library sequencing 90
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome 90
Therapeutic potential of MEK inhibition in acute myelogenous leukemia: rationale for "vertical" and "lateral" combination strategies. 90
WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). 90
Combined pegylated liposomal doxorubicin and bortezomib is highly effective in patients with recurrent or refractory multiple myeloma who received prior thalidomide/lenalidomide therapy 90
CALR mutations in patients with essential thrombocythemia diagnosed in childhood and adolescence. 89
Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up 89
A prospective unicentric survey on donor-specific antibodies DSA and desensitization strategy 89
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008. 89
Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: Results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol 89
Spontaneous regression of chronic lymphocytic leukemia: Clinical and biologic features of 9 cases 88
Defective expression of the T-cell receptor-CD3 zeta chain in T-cell acute lymphoblastic leukaemia. 88
Concurrent search for unrelated cord and volunteer donor in high-risk acute lymphoblastic leukemia 88
Diphtheria toxin fused to variant human interleukin-3 induces cytotoxicity of blasts from patients with acute myeloid leukemia according to the level of interleukin-3 receptor expression 88
Production of tumor necrosis factor?alpha (TNF) by B?cell chronic lymphocytic leukemia cells. A possible regulatory role of TNF in the progression of the disease. 87
Chlorambucil plus rituximab with or without maintenance rituximab as first-line treatment for elderly chronic lymphocytic leukemia patients. 87
Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug nutlin-3: a proposal for clinical application. 87
Thrombopoietin Receptor Activation, Thrombopoietin Mimetic Drugs, and Hereditary Thrombocytosis: Remarks on Bone Marrow Fibrosis. 87
ATM gene alterations in chronic lymphocytic leukemia patients induce a distinct gene expression profile and predict disease progression 87
Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia 87
Expression of Tie-2 and other receptors for endothelial growth factors in acute myeloid leukemias is associated with monocytic features of leukemic blasts 86
Developing a European network for adult ALL. 86
Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223 86
Risk of secondary hypogammaglobulinaemia after Rituximab and Fludarabine in indolent non-Hodgkin lymphomas: a retrospective cohort study 86
null 86
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 86
Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients 86
Incidence and outcome of severe complications in patients with paroxysmal nocturnal hemoglobinuria: A real life scenario from a single center 30 years experience 86
Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. 86
Cyclophosphamide induces a type I interferon-Associated sterile inflammatory response signature in cancer patients' blood cells: Implications for cancer chemoimmunotherapy 86
Dendritic cell generation for leukemia immunotherapy 86
Podocalyxin is expressed in normal and leukemic monocytes 85
Bone Metabolism and Endocrine Function in Children with Chronic Myeloid Leukemia (CML) Treated with Imatinib during Puberty. 85
Totale 11.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 172.472
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 210
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 172.682
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.823 0 0 0 0 0 0 0 0 1.373 1.342 668 440
2020/20213.862 433 517 147 305 200 233 125 456 450 485 368 143
2021/202210.388 152 552 865 825 1.432 319 200 956 707 864 1.413 2.103
2022/20239.886 2.123 2.062 408 994 956 1.140 193 581 908 75 322 124
2023/20244.492 357 669 220 325 321 397 174 198 78 638 539 576
2024/20256.717 603 972 746 685 801 821 1.168 729 192 0 0 0
Totale 57.506